Skip to content
For laboratory research use only · Not for human or veterinary use · Qualified buyers only
Peptides

What Is RU58841? Androgen-Receptor Antagonist Identity and Documentation

A research-use identity note on RU58841, a non-steroidal androgen-receptor antagonist, with attributed follicle-model findings and small-molecule documentation.

What Is RU58841? Androgen-Receptor Antagonist Identity and Documentation

RU58841 is a non-steroidal androgen-receptor antagonist investigated in follicle-biology and androgen-signaling models. The original overview of this page asks three questions: androgen-receptor binding research, solution concentration and vehicle controls, and small-molecule identity and impurity profiling. It is a small molecule, not a peptide. A broader hair-follicle research overview is at Peptides and Compounds in Hair-Follicle Research: Models and Published Findings.

Editorial review: 17 November 2026. Prepared by Velnacor Research Desk for research-use communication only. Published findings below are attributed to the cited papers. They are not claims about a Velnacor lot and are not instructions for use in people or animals.

Androgen-receptor research

Battmann and colleagues characterized RU 58841 as a topical non-steroidal antiandrogen with high affinity for hamster androgen receptors, and they reported dose-dependent regression of hamster flank-organ area after topical application, with limited systemic antiandrogenic activity in those animal models (Battmann et al., 1994). In that sentence, “dose-dependent” is a finding in the animal model they described, not a human-use instruction.

In a controlled study of balding human scalp grafts maintained on testosterone-conditioned nude mice, De Brouwer and colleagues reported higher linear hair growth rates and a larger share of follicles initiating a second cycle in the RU58841-treated group than in the vehicle group (De Brouwer et al., 1997). Pan and colleagues reported that RU58841 competitively suppressed dihydrotestosterone activation of wild-type androgen receptor in a prostate PC3 reporter system, and that topical application increased hair density, thickness, and length in a stumptailed-macaque model, without detected systemic effects in that study (Pan et al., 1998). Obana and colleagues reported that RU 58841 antagonized testosterone-induced inhibition of outer-root-sheath cell proliferation in a macaque dermal-papilla coculture (Obana et al., 1997). Those are findings in the models named. They are not a completed clinical trial and are not a use instruction.

Small-molecule identity, vehicle, and impurities

RU58841 should be documented with methods suited to a small molecule, including identity, impurity profiling, and the vehicle actually used. A purity percentage copied from a peptide template is not a complete file. Third-Party Peptide Testing, Explained and lot traceability still apply as documentation practices.

RU58841 was not found as a standalone published item in Velnacor’s current research-material catalog listing used for this draft. Use the product directory and the COA Library, then confirm whether a current SKU exists and which documents apply in the inquiry. For packing at supply scale, see wholesale peptides.

Solution concentration and vehicle are ordinary small-molecule documentation items. They belong in the protocol and the receiving record for the model actually used—flank organ, graft, reporter assay, or coculture—and they should not be copied from a paper into a use instruction. A vehicle control is part of how the cited animal and cell studies were designed; it is not a reason to treat RU58841 as a finished clinical anti-androgen product. Impurity profiling should use methods suited to this non-steroidal small molecule, not a peptide-only template.

Selected published literature

  1. Battmann T, Bonfils A, Branche C, Humbert J, Goubet F, Teutsch G, Philibert D. RU 58841, a new specific topical antiandrogen: a candidate of choice for the treatment of acne, androgenetic alopecia and hirsutism. Journal of Steroid Biochemistry and Molecular Biology. 1994;48(1):55-60. doi:10.1016/0960-0760(94)90250-X. PubMed 8136306.
  2. De Brouwer B, Tételin C, Leroy T, Bonfils A, Van Neste D. A controlled study of the effects of RU58841, a non-steroidal antiandrogen, on human hair production by balding scalp grafts maintained on testosterone-conditioned nude mice. British Journal of Dermatology. 1997;137(5):699-702. doi:10.1111/j.1365-2133.1997.tb01104.x. PubMed 9415227.
  3. Pan HJ, Wilding G, Uno H, Inui S, Goldsmith L, Messing E, Chang C. Evaluation of RU58841 as an anti-androgen in prostate PC3 cells and a topical anti-alopecia agent in the bald scalp of stumptailed macaques. Endocrine. 1998;9(1):39-43. doi:10.1385/endo:9:1:39. PubMed 9798729.
  4. Obana N, Chang C, Uno H. Inhibition of hair growth by testosterone in the presence of dermal papilla cells from the frontal bald scalp of the postpubertal stumptailed macaque. Endocrinology. 1997;138(1):356-361. doi:10.1210/endo.138.1.4890. PubMed 8977424.

Sourcing notes for qualified buyers

Velnacor’s stated supply terms for qualified research and business buyers include: every batch is third-party tested; orders usually ship within 24 hours, subject to stock, documentation review, and destination; trial orders can start from one box of ten vials; parcels lost or damaged in transit are eligible for free reshipment or a refund; and neutral packaging is available when required. Velnacor operates its own production base and has a long-standing supply-chain business.

Those points describe documentation and fulfillment. They do not describe a laboratory or biological outcome. For an order-specific review, send the material name, specification, box quantity, and destination through the inquiry list.

Research-use notice. All Velnacor products are intended strictly for laboratory research use only. They are not drugs, supplements, or food, and are not intended to diagnose, treat, cure, or prevent any disease. Not for human or veterinary use. Purchasers must be qualified researchers. This article is educational content for laboratory and business readers. It does not provide dosing, reconstitution, administration, diagnostic, or treatment guidance.

My inquiry listNo products added yet0